October 24, 2016 3:12 AM ET


Company Overview of Ceptaris Therapeutics Inc.

Company Overview

Ceptaris Therapeutics Inc. develops mechlorethamine gels. The company develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. Ceptaris Therapeutics, Inc. was formerly known as Yaupon Therapeutics, Inc. and changed its name to Ceptaris Therapeutics, Inc. in January 2012. The company was founded in 2002 and is based in Malvern, Pennsylvania. As of September 19, 2013, Ceptaris Therapeutics Inc. operates as a subsidiary of Actelion US Holding Company.

101 Lindenwood Drive

Suite 400

Malvern, PA 19355

United States

Founded in 2002





Key Executives for Ceptaris Therapeutics Inc.

Ceptaris Therapeutics Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ceptaris Therapeutics Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.